Samsung Biologics Reports Q3 Operating Profit of 56.5 Billion KRW, Up 139% Year-on-Year
[Asia Economy Reporter Minji Lee] Samsung Biologics announced on the 21st that its operating profit for the third quarter reached 56.534 billion KRW. This represents a 139% increase compared to the same period last year. Sales increased by 48% to 274.5 billion KRW, and net profit reached 56 billion KRW, marking a 27% increase.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
